Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on September 04, 2026, sold 25,000 shares in Krystal Biotech (KRYS) for $8,983,084. Following the Form 4 filing with the SEC, Krishnan has control over a total of 1,565,253 common shares of the company, with 1,347,543 shares held directly and 217,710 controlled indirectly.
SEC Filing: